Nuclear Imaging of Differentiated Thyroid Cancer: Current Status and Future Perspective.
- Author:
Shin Young JEONG
1
;
Jaetae LEE
Author Information
1. Department of Nuclear Medicine, Kyungpook National University School of Medicine, Daegu, Korea. jaetae@knu.ac.kr
- Publication Type:Review
- Keywords:
Thyroid cancer;
Nuclear imaging
- MeSH:
Chimera;
Humans;
Molecular Imaging;
Positron-Emission Tomography;
Thyroid Gland;
Thyroid Neoplasms;
Tomography, Emission-Computed, Single-Photon
- From:Journal of Korean Thyroid Association
2011;4(1):8-17
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Nuclear imaging studies have been used for individualized treatment planning, and to optimize management in patients with differentiated thyroid cancer (DTC). Nuclear imaging studies demonstrate whole body distribution of radioactive tracer and are complementary to radiological studies as they give functional information. Recently, hybrid imaging modalities such as single photon emission computed tomography (CT) with integrated CT and positron emission tomography with integrated CT allow the rapid and efficient fusion of functional and anatomical images, and provide diagnostic information that influence management decision in patients with DTC. This article reviewed nuclear imaging studies and hybrid imaging modalities used in patients with DTC, and future perspectives of functional molecular imaging of the thyroid cancer.
